- Home
- Equipment
- philippines
- cancer related lymphedema with early
Show results for
Refine by
Cancer Related Lymphedema With Early Equipment & Supplies In Philippines
25 equipment items found
Manufactured by:HymonBio Co.,Ltd based inSuzhou, CHINA
HAEMOCERT Colorectal Cancer Screening Test has passed CE certification and is used for early colorectal cancer ...
Manufactured by:Shanghai Henlius Biotech, Inc based inShanghai, CHINA
??? (trastuzumab, Zercepac in the EU) was successfully launched in China and Europe, becoming the first Chinese mAb biosimilar entering both the EU and China market. It is indicated for the treatment of HER2 positive early breast cancer, metastatic breast cancer and metastatic gastric cancer, which corresponds to all the approved indications of the trastuzumab originator. ??? is certificated by ...
by:Vivozon Inc. based inYongin-si, SOUTH KOREA
A randomized, double-blind, parallel-group, placebo-controlled clinical trial to evaluate the analgesic efficacy and safety of VVZ-149 Injection in patients who have pain after laparoscopic gastrectomy in early gastric cancer ...
by:Acuamark Diagnostics based inNew York, NEW YORK (USA)
The vast majority of cancer cases are detected at stage III or beyond, resulting in poor cancer survival of ~50% in the aggregate. Cancer cases are forecasted to reach 25M per year over the next two decades, causing deaths to rise to 13M per year (worldwide). Annually, the worldwide economic impact of cancer is estimated by the WHO at $1.2 trillion. ...
Manufactured by:PREVENTIS GMBH based inBensheim, GERMANY
The immunological occult blood test PreventID® CC is a rapid test for self-testing for the qualitative detection of the valuable red blood pigment hemoglobin in stool as a marker for intestinal bleeding. The result can be read after 10 minutes. According to the WHO, colorectal cancer is the third most common cancer worldwide, with approximately 1.9 million new cases in 2020. In Germany ...
Manufactured by:PREVENTIS GMBH based inBensheim, GERMANY
The immunological occult blood test PreventID® CC is a rapid test for self-testing for the qualitative detection of the valuable red blood pigment hemoglobin in stool as a marker for intestinal bleeding. The result can be read after 10 minutes. ...
Manufactured by:GENCURIX based inGuro-gu, SOUTH KOREA
Multigene prognostic test predicts the probability of metastasis or recurrence, which helps patients make treatment decision. It improves quality of life for cancer patients as preventing them from unnecessary ...
Manufactured by:VIDAR Systems Corporation based inHerndon, VIRGINIA (USA)
The CAD PRO® Advantage film digitizer is specifically designed for mammography CAD. CAD systems incorporate advanced pattern recognition and image analysis, requiring a film digitizer that meets the highest standards of image quality and reliability. These advanced systems enable radiologists to improve their ability to detect early stage cancers in an efficient manner. The CAD PRO Advantage ...
by:Ezra based inGeorgetown, TEXAS (USA)
Ezra offers advanced MRI-based full-body scans aimed at early cancer detection. The service employs 3 Tesla (3T) MRI technology, known for its higher-resolution imaging and superior signal-to-noise ratio, alongside 1.5 Tesla (1.5T) MRI for broader accessibility. These scans are designed to identify potential early-stage cancers, significantly improving survival rates. Due to telehealth ...
Manufactured by:Abviris Deutschland GmbH based inAhrensburg, GERMANY
Innovative solutions for the serological detection of HPV16 induced cancer. From a diagnostics point of view it is irrelevant to detect the very common HPV infections but rather important to identify HPV induced deseases. The presence of increased HPV16 L1 antibodies is a highly specific indicator for altered cells in patients which have not been vaccinated against HPV. An elevated level of these ...
Manufactured by:Rarecells Diagnostics SAS based inParis Cedex 06, FRANCE
Cancer is the second cause of death, accounting for nearly 9 million deaths in 2017 all over the world. In 2019, 1,762,450 new cancer cases and 606,880 cancer deaths are projected to occur in the United States. It is estimated that metastasis is the primary cause of 90% of all cancer-related deaths. Circulating Tumor Cells (CTCs) detection and analysis are the foundation of non-invasive tests ...
Manufactured by:GENCURIX based inGuro-gu, SOUTH KOREA
What is early diagnosis? Early diagnosis helps people to plan ahead while they are still able to make important decisions on their care and support needs and on financial and legal ...
Manufactured by:Panagene Inc. based inDaejeon, SOUTH KOREA
Lung cancer is a metastatic cancer which the cancer cells are developed in the bronchial tubes or alveoli and grow along the blood vessel or lymphatic vessel. There are two types of lung cancer based on the sizes and shape of the cancer cell; non-small cell lung cancer (NSCLC) takes 75% and small cell lung cancer takes 25%. Usually, it is hard to find lung cancer in the early stage and is ...
Manufactured by:Datar Cancer Genetics based inGuildford, UNITED KINGDOM
Cancertrack is an advanced non-invasive blood test which provides real time intel on the status of a malignancy from a safe, simple and quick blood draw. Cancertrack profiles molecular features in circulating tumor DNA and circulating tumor RNA and also evaluates ‘Circulating Tumor Cells’ ...
Manufactured by:Digital Diagnostics Inc. based inCoralville, IOWA (USA)
Our autonomous AI research expands the reach of dermatological care beyond the exam room, from skin cancer to inflammatory disease. We are currently recruiting pilot locations and research groups interested in skin diagnostics and ...
Manufactured by:MicroPort Scientific Corporation based inShanghai, CHINA
Toumai™ Endoscopic Surgery Robot successfully completed its First-In-Man (FIM) trial for Robot Assisted Laparoscopic Radical Prostatectomy (RALRP) at Shanghai Oriental Hospital on November 1st 2019. Under the guidance of Academician Sun Yinghao, RALRP was provided to a 65 year old local patient, who was admitted to the hospital for early prostate cancer, the whole surgery lasted 1.5 hours. ...
Manufactured by:INOVIQ Ltd based inNotting Hill, AUSTRALIA
INOVIQ has the exclusive worldwide license for SubB2M - an engineered protein that binds to a unique sugar molecule called Neu5Gc which is only present in human cancers. In initial clinical studies, SubB2M has detected cancers with 100% sensitivity and specificity for mid to late-stage cancers, and >95% specificity and 100% sensitivity for early-stage cancers. There is also evidence that ...
Manufactured by:Pacific Edge Ltd based inDunedin,, NEW ZEALAND
Cxbladder is a non-invasive genomic urine test that quickly and accurately detects or rules out bladder cancer. The tests works at a molecular level, measuring five biomarker genes to detect the presence or absence of bladder cancer1, and comes as a suite of three product variations, each optimised for a different point in the patient ...
Manufactured by:InSphero AG based inSchlieren, SWITZERLAND
An in vitro PDX model with in vivo-like heterogeneity. 3D InSight™ Tumor Microtissues from Patient-Derived Xenografts (PDX) are custom assay-ready 3D in vitro tumor models engineered to reflect complex tumor biology without the use of artificial matrices. Ideal for early stage cancer drug efficacy testing and screening appliciations, these advanced cancer models help bridge the gap between ...
Manufactured by:IMB Dx, Inc. based inSeoul, SOUTH KOREA
Cell-free DNA (cfDNA) is circulating fragments of DNA that is released from cells into the circulatory system throughout the body. Tumor cells also release DNA into the blood stream, which is called circulation-tumor DNA(ctDNA). IMBdx Inc.’s AlphaLiquid® platform offers industry-leading ctDNA-based precision diagnostics solutions across the full continuum of cancer care, from therapy ...